Literature DB >> 16909918

Host antimicrobial defence peptides in human disease.

B Agerberth1, G H Gudmundsson.   

Abstract

Antimicrobial peptides or host defence peptides are endogenous peptide antibiotics, which have been confirmed as an essential part of the immune system. Apart from direct killing of bacteria, a role for the peptides in antiviral and immunomodulatory functions has recently been claimed. In this chapter we have focused on the host contact with microbes, where these host defence peptides are key players. The interplay with commensals and pathogens in relation to antimicrobial peptide expression is discussed, with specific emphasis on the respiratory and the alimentary systems. A possible novel difference in epithelial interactions between commensals and pathogens is considered in relation to disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909918     DOI: 10.1007/3-540-29916-5_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  22 in total

1.  The POU transcription factor Drifter/Ventral veinless regulates expression of Drosophila immune defense genes.

Authors:  Anna Junell; Hanna Uvell; Monica M Davis; Esther Edlundh-Rose; Asa Antonsson; Leslie Pick; Ylva Engström
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

2.  Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.

Authors:  Viswanatha Krishnakumari; Nandini Rangaraj; Ramakrishnan Nagaraj
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

3.  Do antimicrobial peptides and antimicrobial-peptide resistance play important roles during bacterial infection?

Authors:  Gordon Yc Cheung; Michael Otto
Journal:  Future Microbiol       Date:  2018-08-16       Impact factor: 3.165

4.  Antimicrobial Peptide Resistance Mechanism Contributes to Staphylococcus aureus Infection.

Authors:  Gordon Y C Cheung; Emilie L Fisher; Joshua W McCausland; Justin Choi; John W M Collins; Seth W Dickey; Michael Otto
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

Review 5.  Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.

Authors:  Charles R Wira; Mickey V Patel; Mimi Ghosh; Lucy Mukura; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-03       Impact factor: 3.886

6.  Rattusin, an intestinal α-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities.

Authors:  Amar A Patil; Andre J Ouellette; Wuyuan Lu; Guolong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

7.  Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.

Authors:  Bruno Rivas-Santiago; Rogelio Hernandez-Pando; Claudia Carranza; Esmeralda Juarez; Juan Leon Contreras; Diana Aguilar-Leon; Martha Torres; Eduardo Sada
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

8.  Identification of an orphan response regulator required for the virulence of Francisella spp. and transcription of pathogenicity island genes.

Authors:  Nrusingh P Mohapatra; Shilpa Soni; Brian L Bell; Richard Warren; Robert K Ernst; Artur Muszynski; Russell W Carlson; John S Gunn
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

Review 9.  Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.

Authors:  Yan Campbell; Mary L Fantacone; Adrian F Gombart
Journal:  Eur J Nutr       Date:  2012-07-15       Impact factor: 5.614

10.  Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.

Authors:  Peter G Barlow; Pavel Svoboda; Annie Mackellar; Anthony A Nash; Ian A York; Jan Pohl; Donald J Davidson; Ruben O Donis
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.